Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Covid/had it once before/taken Paxlovid; Covid/had it once before/taken Paxlovid; got Covid again/was prescribed Paxlovid; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 4 (BOOSTER), SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 5 (BOOSTER), SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 6 (BOOSTER), SINGLE), for Covid-19 immunization; Bnt162b2 (DOSE 7 (BOOSTER), SINGLE), for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid/had it once before/taken Paxlovid"; DISEASE RECURRENCE (medically significant), outcome "unknown", described as "got Covid again/was prescribed Paxlovid". Therapeutic measures were taken as a result of drug ineffective, covid-19, disease recurrence. Clinical course: It was reported that the patient received 8 Pfizer COVID-19 vaccine shots, had COVID, had it once before and taken Paxlovid. The patient got COVID again and was prescribed Paxlovid. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.